| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
(Country) | 2. Date of Event Requiring Statement
(Month/Day/Year) 03/18/2026 | 3. Issuer Name and Ticker or Trading Symbol
Alarum Technologies Ltd. [ ALAR ] | |||||||||||||||
| 3a. Foreign Trading Symbol
| 5. If Amendment, Date of Original Filed
(Month/Day/Year) | ||||||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| 6. Individual or Joint/Group Filing (Check Applicable Line)
| ||||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Ordinary Shares | 450,000(1) | D | |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Options (Right to buy) | (3) | 08/25/2031 | Ordinary Shares | 19,583 | $1.282(2) | D | |
| Stock Options (Right to buy) | (5) | 11/28/2032 | Ordinary Shares | 350,004 | $0.407(4) | D | |
| Explanation of Responses: |
| 1. Includes (i) 50,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in 4 equal quarterly installments of 12,500 Ordinary Shares through January 19, 2027; and (ii) 87,500 Ordinary Shares issuable upon the vesting of RSUs through October 19, 2027 in 7 equal quarterly installments of 12,500 Ordinary Shares; and (iii) 125,000 Ordinary Shares issuable upon the vesting of RSUs through July 19, 2028 in 10 equal quarterly installments of 12,500 Ordinary Shares. |
| 2. The options were granted with an exercise price of NIS 4.00 and have been converted based on the ratio of $1.282 as of March 16, 2026. |
| 3. The options were granted on August 25, 2021 and fully vested as of August 25, 2024. |
| 4. The options were granted with an exercise price of NIS 1.27 and have been converted based on the ratio of $0.407 as of March 16, 2026 |
| 5. The options were granted on November 28, 2022 and fully vested as of November 28, 2025. |
| /s/ Shai Avnit | 03/19/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
| * Form 3: SEC 1473 (03-26) | ||